160 related articles for article (PubMed ID: 12528117)
1. Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.
Bolstad AI; Eiken HG; Rosenlund B; Alarcón-Riquelme ME; Jonsson R
Arthritis Rheum; 2003 Jan; 48(1):174-85. PubMed ID: 12528117
[TBL] [Abstract][Full Text] [Related]
2. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
[TBL] [Abstract][Full Text] [Related]
3. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
Ping L; Ogawa N; Sugai S
Arthritis Rheum; 2005 Feb; 52(2):573-81. PubMed ID: 15692983
[TBL] [Abstract][Full Text] [Related]
4. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Nakajima A; Azuma M; Okumura K; Sumida T
Clin Exp Rheumatol; 1998; 16(5):561-8. PubMed ID: 9779303
[TBL] [Abstract][Full Text] [Related]
5. Fas-Fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis.
Campanelli AP; Martins GA; Souto JT; Pereira MS; Livonesi MC; Martinez R; Silva JS
J Infect Dis; 2003 May; 187(9):1496-505. PubMed ID: 12717632
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
7. Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.
Bolstad AI; Wargelius A; Nakken B; Haga HJ; Jonsson R
J Rheumatol; 2000 Oct; 27(10):2397-405. PubMed ID: 11036836
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
[TBL] [Abstract][Full Text] [Related]
9. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome.
Sumida T; Matsumoto I; Murata H; Namekawa T; Matsumura R; Tomioka H; Iwamoto I; Saito Y; Mizushima Y; Hasunuma T; Maeda T; Nishioka K
J Immunol; 1997 Jan; 158(2):1020-5. PubMed ID: 8993025
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.
Azuma M; Motegi K; Aota K; Hayashi Y; Sato M
Lab Invest; 1997 Sep; 77(3):269-80. PubMed ID: 9314950
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.
Saito I; Haruta K; Shimuta M; Inoue H; Sakurai H; Yamada K; Ishimaru N; Higashiyama H; Sumida T; Ishida H; Suda T; Noda T; Hayashi Y; Tsubota K
J Immunol; 1999 Mar; 162(5):2488-94. PubMed ID: 10072487
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
Kong L; Robinson CP; Peck AB; Vela-Roch N; Sakata KM; Dang H; Talal N; Humphreys-Beher MG
Clin Exp Rheumatol; 1998; 16(6):675-81. PubMed ID: 9844759
[TBL] [Abstract][Full Text] [Related]
14. [Effect of nourishing Yin, strengthening Qi and activating blood decoction on Fas/FasL in salivary glands of NOD mice with Sjogren's syndrome and their mRNA expression].
Wu GL; Li TY; Lu WW; Yu GY; Fan YS
Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4148-51. PubMed ID: 24791507
[TBL] [Abstract][Full Text] [Related]
15. FasL:Fas ratio--a prognostic factor in breast carcinomas.
Reimer T; Herrnring C; Koczan D; Richter D; Gerber B; Kabelitz D; Friese K; Thiesen HJ
Cancer Res; 2000 Feb; 60(4):822-8. PubMed ID: 10706087
[TBL] [Abstract][Full Text] [Related]
16. Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome.
Gannot G; Bermudez D; Lillibridge D; Fox PC
Cell Death Differ; 1998 Sep; 5(9):743-50. PubMed ID: 10200533
[TBL] [Abstract][Full Text] [Related]
17. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
Zhou W; Dong Y; Zhao Y; Tang FL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
[TBL] [Abstract][Full Text] [Related]
18. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium.
Hamann KJ; Dorscheid DR; Ko FD; Conforti AE; Sperling AI; Rabe KF; White SR
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):537-42. PubMed ID: 9761749
[TBL] [Abstract][Full Text] [Related]
20. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome.
Kong L; Ogawa N; Nakabayashi T; Liu GT; D'Souza E; McGuff HS; Guerrero D; Talal N; Dang H
Arthritis Rheum; 1997 Jan; 40(1):87-97. PubMed ID: 9008604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]